T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...

Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...

Teclistamab-cqyv (Tecvayli) led to clinically meaningful responses in patients with heavily pretreated multiple myeloma who ...

Thymagen peptide has garnered attention within scientific circles due to its hypothesized impact on various biological ...

Teclistamab shows promising results in high-risk multiple myeloma patients, including those ineligible for trials due to ...

In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Fluorescent proteins are proteins that absorb light and re-emit it at a longer wavelength. They can be genetically encoded as fusions to other proteins to act as labels. Neuromodulators that ...